Search research articles
Contact Us
Filters
Showing results (601-610 of 625) with videos related to
Page
of 63
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 2026
Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project
Miguel A Molina-Vila, Zoi Tsourti, Katerina Vervita, et al.
Pain
|
June 17, 2021
International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
Simon Haroutounian, Lars Arendt-Nielsen, Joletta Belton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project
Stephen P Finn, Alfredo Addeo, Urania Dafni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer
Emma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
BMJ Open
|
May 17, 2018
Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol
Robert U Newton, Stacey A Kenfield, Nicolas H Hart, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 16, 2011
Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases
Craig A Zificsak, Diane E Gingrich, Henry J Breslin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
John M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer
Teodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer
Teodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 17, 2022
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
Jan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Page
of 63
Search research articles
Search
Showing results (601-610 of 625) with videos related to
Sort By:
Page
of 63
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 2026
Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project
Miguel A Molina-Vila, Zoi Tsourti, Katerina Vervita, et al.
Pain
|
June 17, 2021
International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
Simon Haroutounian, Lars Arendt-Nielsen, Joletta Belton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project
Stephen P Finn, Alfredo Addeo, Urania Dafni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer
Emma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
BMJ Open
|
May 17, 2018
Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol
Robert U Newton, Stacey A Kenfield, Nicolas H Hart, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 16, 2011
Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases
Craig A Zificsak, Diane E Gingrich, Henry J Breslin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
John M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer
Teodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer
Teodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 17, 2022
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
Jan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Page
of 63